Syngene locks in Bristol Myers Squibb alliance through 2035
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
Over 8.8?million Indians aged 60 and above currently live with dementia,
Eltrombopag tablets will be produced at the group’s formulation manufacturing facility at SEZ, Ahmedabad
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
The partnership will launch a Phase 1b cohort within Boehringer’s ongoing Beamion-BCGC1 trial
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
Subscribe To Our Newsletter & Stay Updated